M

Type 2 Diabetes Defeated

Diabetes Holistic Treatment

Get Instant Access

Manganese, daily dietary intake of, 603/ Mannitol, 550/, 551 Mantoux test, 473 MAO. See Monoamine oxidase MAP. See Mean arterial pressure MAPCs. See Multipotent adult progenitor cells Maple-syrup disease, 93i Margarine, saturated fat content of, 34 Marijuana, and neuron activity, 178, 181 Mass action, law of, 91, 510 Mass activation, of sympathetic neurons, 222 Mast cells, 452-453 Mastication, 561, 563 Mathematical calculations, cerebral area related to, 202

Matrix extracellular, 53, 126-127 of mitochondrion, 57 Matrix metalloproteinases (MMPs), 127 Mature (graafian) follicles, 657 Maturity-onset diabetes. See Diabetes mellitus, type 2 Maximal oxygen uptake, 346-347 Mean arterial pressure (MAP), 419-420, 435 Measurement blind, 5

in experiments, 4-5 quantitative, 5 Mechanoreceptors, 242, 243/ Median eminence, 301 Mediastinum, 483 Medulla oblongata, 208 and autonomic nervous system, 236 cardiac control center in, 409, 431 chemoreceptors in, 501-502, 502/ nuclei in, 207, 208

respiratory control center in, 208, 208/,

499, 500/ structure of, 208 vasomotor control center in, 431 Megakaryocytes, 369 Meiosis, 75-78, 76/, 77/, 634, 647, 647/ Meissner's corpuscles, 244, 245/ Meissner's plexus, 562/, 563, 585 Melanin, 19 granules of, 56

inborn errors in metabolism of, 92, 93/ Melanocortin, 606

Melanocyte-stimulating hormone (MSH).

300, 606 Melanoma, 72 Melatonin exogenous, 315 production of, 314, 643, 643/ secretion of, 205, 289, 314-315, 314/, 643 Membrane(s). See specific membranes transport across (See Active transport; Diffusion) Membrane attack complex, 457, 457/ Membrane potentials, 140-143 action potentials and, 161-165 ion gating and, 161 resting, 142-143, 143/ depolarization of, 161 hyperpolarization of, 161 in neurons, 160-161 repolarization of, 161 visualization of, 160, 160/ Membranous labyrinth, 251, 252/ Memory cerebral areas related to, 201-202 long-term, 201 neural stem cells and, 203 short-term, 201 synaptic changes in, 202-203 Memory cells, 453, 454/ Menarche, 642 Méniere's disease, 255 Menopause, 664-665

sex steroids and, 645 Menorrhagia, 663 Menstrual cycle, 659-665, 662/ endometrium in, 662-663 hormonal changes during, 660-661, 661 / phases of, 660-661, 663/, 664/ Menstrual phase, of endometrium, 663 Menstruation, 659 abnormal, 663 pheromones and, 305 Merkel's discs, 244, 245/ Merocrine sweat glands, 14 Mesencephalon. See Midbrain Mesenchymal stem cells, 64 Mesenteric ganglia inferior, 222, 224/ superior, 222, 224/

Mesenteric lymph nodes, 401 / Mesoderm, 670

Mesolimbic dopamine system, 178 Mesonephric (wolffian) ducts, 637 Messenger, second. See Second messenger system(s) Messenger RNA (mRNA), 44 codons of, 65-66, 66t function of, 61, 65-66, 68/ precursor, 64, 65/ synthesis of, 64, 65/ Metabolic acidosis, 377, 377t, 378t, 548-549 Metabolic alkalosis, 377-378, 377t, 378t,

548-549 Metabolic rate basal, 598, 608

thyroxine and, 309, 620-621 caloric requirements and, 598-599 measurement of, 598 Metabolism, 102-119 aerobic, 104, 108-114 anaerobic, 105-106 and blood flow, 422, 427 by body system, 120 Cori cycle in, 108, 109/ definition of, 104 differentiation of, 118-119 end-product inhibition in, 91, 92/ glycogenesis in, 107-108, 107/ glycogenolysis in, 107-108, 107/ glycolysis in, 104-105, 106/ inborn errors of, 91-92, 92/, 93t lactic acid pathway in, 105-106, 106/ of lipids, 114—116, 114/ pathways of, 91-92, 91 / of proteins, 116-118, 118/, 119/ rate of (See Metabolic rate) regulation of, 596-628 adipose tissue in, 605-608 by adrenal hormones, 618-620 by growth hormone, 618-619, 621-622, 621/ hormonal, 609, 609/, 610/, 610t by islets of Langerhans, 611-614 nutritional requirements and, 598-603 by thyroxine, 618-619, 620-621 Metalloproteinase, and extracellular matrix breakdown, 127 Metaphase, 71/ 72, 73/ 74 Metaphase I, 76, 76t, 77/ Metaphase II, 76, 76t, 77/ Metastasis, 468 Metencephalon, 207

development of, 191 Methane, 26/ Methemoglobin, 504-505 Methionine, as essential amino acid, 117t N-Methyl-D-aspartate (NMDA) receptors, 179 and memory, 202 Metrorrhagia, 663

MHC. See Major histocompatibility complex MHC molecules, 460-462 MI. See Myocardial infarction Mice knockout, 71-72 ob/ob, 606 Micelles, 37, 37/ 579

mixed, 589-590, 590/ Microalbuminuria, 551 Microfilaments in cytoplasm, 56 function of, 50t structure of, 50t Microflora, intestinal, 573-574 Microglia, 155/

function of, 155, 156t Microgravity, and bone resorption, 624 Microtubules, 51 / in centrioles, 74 in cilia and flagella, 55, 55/ in cytoplasm, 56, 56/ function of, 50t structure of, 50t, 55 Microvilli, 55, 55/ and rate of diffusion, 130 in small intestine, 55/, 130, 569, 570, 570/ Micturition reflex, 525-526 dual innervation and, 235 Midbrain, 204/, 206 development of, 191, 191 / structure of, 206 Middle ear, 255-256, 256/ MIF. See Mullerian inhibition factor Mifepristone (RU486), 668 Milk, production of, 677, 678/

Milk-ejection reflex (milk letdown), 677,

678, 678/ Mineral(s), 602 recommended dietary allowances for, 601t, 603t Mineralocorticoids, 306 inadequate secretion of, 307 in metabolic regulation, 619 synthesis of, 306, 306/ MIT. See Monoiodotyrosine Mitochondria, 51/ 57, 58/ function of, 50t, 57 structure of, 50t, 57 Mitosis, 71/, 72-75, 73/ Mitral stenosis, 382 Mitral valve, 382 Mixed nerves, 154, 212, 213 MLCK. See Myosin light-chain kinase MMPs. See Matrix metalloproteinases Modalities, of sensation, 242 Molality, 131-132 Molar, 28 Molarity, 131-132 Mole, 131 Molecules, 25-27 organic, 29-31 reduced, 96 signaling, 298 Molybdenum, daily dietary intake of, 603t Monoamine(s), as neurotransmitters, 176-178 Monoamine oxidase (MAO) degradation of monoamines by, 176 pH optimum of, 90t Monoamine oxidase (MAO) inhibitors, 176 Monoblasts, 371

Monoclonal antibodies, 467, 467/ Monocytes, 369, 370/, 370t, 446, 447 in local inflammation, 452, 453/ structure of, 369 Monoglycerides absorption of, 590, 591 / production of, 589, 590/ Monoiodotyrosine (MIT), 309 Mononuclear phagocyte system, 446-447 Monosaccharides, 31-32 Monosynaptic stretch reflex, 349, 350, 350t Morphine and dopaminergic neuron activity, 178 dopaminergic neurons and, 206 Morula, 667, 668/ Mosquitoes, and filariasis, 415 Motilin, 585 Motility definition of, 561 intestinal, 571-572 Motion sickness, 236

Motivation, cerebral area related to, 200-201 Motor end plate, 174, 328, 328/ Motor fibers, 154 in cranial nerves, 212 in spinal nerves, 213, 214/ Motor functions of cerebral cortex, 193 spinal cord tracts in, 209-211 Motor neurons autonomic, 153t, 154, 220-221 and central nervous system, 154/, 190 coactivation of, 350 function of, 1531, 154 lower, 347-348 alpha, 349-350 coactivation of, 350 gamma, 349-350 in skeletal muscle control, 347-352 in skin, 18, 18/ somatic, 153t, 154, 220 structure of, 152/ upper, 193, 347, 350, 352, 353t Motor units, 328-329, 329/ Mountain sickness, acute, 515, 549 Mouse knockout, 71-72 ob/ob, 606 MRI. See Magnetic resonance imaging mRNA. See Messenger RNA MSH. See Melanocyte-stimulating hormone Mucopolysaccharides. See Proteoglycans Mucosa, 562, 562/, 567/ Mucous glands, in digestive tract, 14 Mucus in respiratory system, 483 secretion of, 566 Mullerian (paramesonephric) ducts, 637 Mullerian inhibition factor (MIF), 637 Multiple sclerosis (MS), 158, 470t matrix metalloproteinases in, 127

Multiplier system, countercurrent.

534-536, 535/ Multipolar neurons, 154, 155/ Multipotent adult progenitor cells

(MAPCs), 669 Multipotent cells, 669 Multipotent growth factor-1, 371 Multispecific organic anion transport carriers, 579 Murad, Ferid, 7t Murmurs, heart, 382-383 Muscarinic ACh receptors, 171, 173, 173/,

232, 233/, 233t Muscle(s), 10-11. See also Cardiac muscle; Skeletal muscle; Smooth muscle in breathing, 488, 489/ relaxation of, 338 types of, 10-11 Muscle cells, action potentials in, 336 Muscle myoglobin, 509-510 Muscular arteries, 391-392 Muscular dystrophy creatine kinase and, 344 Duchenne's, 326

plasma enzyme concentrations and, 88t Muscular system cells of, 79

circulatory system and, 359, 440 components of, 19t digestive system and, 359, 592 endocrine system and, 319, 359 functions of, 19t immune system and, 474 integumentary system and, 359 membrane transport in, 145 metabolism in, 120 nervous system and, 237, 359 reproductive system and, 359, 680 respiratory system and, 359, 516 sensory system and, 277 skeletal system and, 359 urinary system and, 359, 553 Muscularis, 562/, 563 Muscularis externa, 572 Muscularis mucosae, 562, 562/ Music, composition vs. understanding of, cerebral area related to, 198 Myasthenia gravis, 172, 174, 470t Myelencephalon, 208 development of, 191 Myelin sheath, 156-157 in central nervous system, 156, 157 and conduction, 165/, 166-167, 166/ destruction of, in multiple sclerosis, 158 formation of, 155/, 156, 156/, 157/ in peripheral nervous system, 156, 157 Myelin-associated inhibitory proteins, and axon regeneration, 158 Myeloblasts, 371 Myeloid tissue, 371 Myenteric plexus, 562/, 563, 585 Myoblasts, 10

Myocardial cells, 10-11, 354, 354/, 378, 384

action potentials in, 385-386, 385/, 386/ capillaries and, 423 Myocardial infarction (MI), 354, 397

plasma enzyme concentrations and, 88t Myocardial ischemia, 107, 397, 397/, 423 Myocardium, 354, 378, 384

blood flow to, 423 Myoepithelial cells, 14 Myofibers. See Skeletal muscle, fibers of Myofibrils, 330, 330/ Myofilaments, 330

Myogenic control mechanisms, in blood flow, 422, 427 Myoglobin, 41t, 509-510 dissociation curve for, 509-510, 509/ muscle, 509-510 in myocardium, 423 Myometrium, 654, 654/ Myoneural (neuromuscular) junctions,

167, 174 Myopia, 267, 267/ Myosin, 38, 56 in cardiac muscle contractions, 410 in skeletal muscle contractions, 330, 334, 334/

in smooth muscle contractions, 356-357 structure of, 334/ Myosin ATPase, 334, 345/ Myosin light-chain kinase (MLCK), 356 Myosin phosphatase, in smooth muscle contraction, 357 Myxedema, 310, 415

n-3 fatty acids, 600

NAD. See Nicotinamide adenine dinucleotide Nafarelin, 641 Naloxone, 180

National Library of Medicine, 5 Natriuresis, 418 Natriuretic hormone, 418, 546 Natriuretic peptide (factor), atrial, 546 Natural killer (NK) cells, 448, 469 Nature (journal), 5 Nature Medicine (journal), 5 Nearsightedness. See Myopia Necrosis, 72, 397

Negative feedback loops. See Feedback control, negative Neonate(s) hemolytic disease of newborn, 374 immunity in, 466 jaundice in, 577

sudden infant death syndrome and, 503 vascular resistance in, 497 Neoplasms, angiogenesis and, 393 Neostigmine, and neural control of skeletal muscles, 172t Nephron(s), 526 cortical, 528, 528/ juxtamedullary, 526-528, 528/ tubules of, 526-528, 527/ reabsorption in, 532-534, 533/ Nernst equation, 141-142 Nerve(s) classification of, 154 definition of, 153t, 154 secretion by, mechanism for, 54 Nerve cells. See Neuron(s) Nerve energies, law of specific, 242-243 Nerve gas, action of, 172t, 174 Nerve growth factor (NGF), 158 Nerve impulses, 143. See also Action potentials Nerve tissue, 11, 11 /

Nervous system. See also Autonomic nervous system; Central nervous system; Neuron(s) cells of, 79

circulatory system and, 237, 440 components of, 19t, 153t digestive system and, 237, 592 endocrine system and, 237, 319 enteric, 563, 585, 586/ functions of, 19t immune system and, 237, 474 integumentary system and, 237 membrane transport in, 145 metabolism in, 120 muscular system and, 237, 359 regulation by, 9

reproductive system and, 237, 680 respiratory system and, 237, 516 sensory system and, 277 skeletal system and, 237 urinary system and, 237, 553 Neural crest, 190, 191/ Neural stem cells, 64, 156, 193, 669 and learning, 203 and memory, 203 Neural tube, 190, 191 / Neurilemma, 156 Neuroendocrine reflexes, 301, 677 Neurofibrillar tangles, in Alzheimer's disease, 175, 194 Neurogenesis, 193, 203 Neurogenic mechanism, of breathing and exercise, 513 Neurogenic shock, 439 Neuroglia, 152

Neuroglial cells, 11, 152, 155/ Neurohormones, 286 Neurohypophysis. See Pituitary gland, posterior Neuroleptics, 178 Neuromodulators, 180

Neuromuscular junction, motor end plates at,

328, 328/ Neuromuscular junctions, 167, 174 Neuron(s), 152-154. See also speci/ic types cable properties of, 164-165 classification of functional, 154 structural, 154 components of, 11 definition of, 152

functions of, 152 long-term potentiation in, 182 membrane potential of, alteration of, 160-161 production of, 193 regeneration of, 157-158, 158/ structure of, 152-153, 152/, 153/ synapses in, 167-170 Neuronal cell death, 182 Neuropeptide(s), 179-180 Neuropeptide Y, 180-181, 606 Neurotransmitters, 144. See also specific substances in autonomic nervous system, 175,

227-234 early research on, 167 and eating, 605 excitatory, 179 vs. hormones, 289-290 inhibitory, 179

parasympathetic release of, 229/ receptor proteins for, 169 release of, 168-169, 169/ sympathetic release of, 229/ in synaptic inhibition, 182-183 Neurotrophin(s), 158, 316-317, 316t Neurotrophin-3, 158 Neurotrophin-4/5, 158 Neutral fats, 35 Neutral pH, 28 Neutrons, 24

Neutrophil(s), 369, 370/, 370t, 446 abundance of, 369 apoptosis of, 72 functions of, 447, 448/ in local inflammation, 452, 453/ structure of, 369 New England Journal o/Medicine, 5 Newborn. See Neonate(s) News in Physiological Sciences, 5 NGF. See Nerve growth factor Niacin, 96, 601, 602t recommended dietary allowance for, 601t Nicotinamide adenine dinucleotide (NAD) action of, 98/

in aerobic respiration, 108-114, 109/ in glycolytic-lactic acid pathway, 104-105 as hydrogen carrier, 96, 97/ structure of, 97/ Nicotine dopaminergic neurons and, 178, 206 synaptic effects of, 207t Nicotinic ACh receptors, 171, 171/, 206, 232,

233/, 233t Nidation, 667

NIDDM (non-insulin-dependent diabetes mellitus). See Diabetes mellitus, type 2 Niedergerde, R., 7t Nifedipine, 357

Nigrostriatal dopamine system, 178, 206 Nissl bodies, 152 Nitric oxide altitude and, 514-515 as autocrine regulator, 316t and erection, 651, 653/ free radicals of, diseases associated with, 111 as neurotransmitter, 144, 180t, 181,

233-234 as paracrine regulator, 316-317

of blood flow, 421-422 as retrograde messenger, 202 and septic shock, 438 Nitric oxide radical, 603 Nitric oxide synthase, 438, 459 Nitrogen balance, 116

in blood, disorders associated with, 499 partial pressure of, 493 reactive species of, 603 structure of, 24t Nitrogen narcosis, 499 Nitrogenous base, of nucleotides, 42 Nitroglycerin, 422 NK. See Natural killer N-Methyl-D-aspartate (NMDA) receptors,

179, 202 Nociceptors, 242, 243t, 244 Nodes of Ranvier, 157

action potentials at, 165/ 166 Non-insulin-dependent diabetes mellitus (NIDDM). See Diabetes mellitus, type 2

Nonkeratinized membrane, 12, 12t, 13/ Nonshivering thermogenesis, 608-609

Nonsteroid family, of hormone receptors, 292 Nonsteroidal anti-inflammatory drugs (NSAIDs), 318 excessive use of, 551 and gastric ulcers, 568 Nonvolatile acids, 377-378 Norepinephrine and cardiac contraction strength, 411 and cardiac rate, 408 chemical structure of, 229/ and eating, 605 as hormone, 176 hypersecretion of, 307 metabolic regulation by, 619 as neurotransmitter, 176, 177/ 178, 180/ in autonomic nervous system, 228 responses to, 230-231 secretion of, 223, 289, 307 Normoblasts, 371, 372/ Norplant, 664

NSAIDs. See Nonsteroidal anti-inflammatory drugs

Nuclear bag fibers, 348 Nuclear chain fibers, 348 Nuclear envelope, 50/, 51/ 61 Nuclear hormone receptors, 292-294 Nuclear pore(s), 61, 62/ Nuclear pore complexes, 61, 62/ Nuclear receptors, 579 Nucleic acids, 38, 42-44 Nucleolus, 51/ function of, 50/, 51, 61 structure of, 50/ Nucleosomes, 62 Nucleotides, 42, 42/ in DNA, 42, 44/, 62 in RNA, 44, 44/ Nucleus(i) (cell), 51/, 61-64 function of, 51 structure of, 24, 51, 61, 61/ transplantation of, 668-669 Nucleus(i) (nervous system), 152-153, 153/ amygdaloid, 200, 202, 249 basal, 197, 197/, 211, 211/, 352 caudate, 197, 352 composition of, 192 geniculate lateral, 204, 274, 276 medial, 204 intralaminar, 204 lentiform, 197

paraventricular, 205, 205/, 301 red, 206, 211, 211/ septal, 200 suprachiasmatic, 314 supraoptic, 205, 205/, 301 vagus, 208 vestibular, 211, 211/ Nucleus accumbens, dopaminergic pathways and, 178 Null hypothesis, 5 Nutritional requirements, 598-603 Nystagmus, vestibular, 254-255

ob gene, 606

Obesity, 608

ob/ob mice, 606

Occipital lobe, 193, 194/, 194t

Oculomotor nerve, 212t, 225t parasympathetic fibers in, 223 Oddi, sphincter of, 581 Off-center fields, 275, 276/ Olfaction, 249-250 cerebral area related to, 200, 249 emotion and, 249 molecular basis of, 249-250 neural pathway for, 249, 250/ receptors for, 248, 249-250 Olfactory bulb, 249, 250/ Olfactory nerve, 212t, 250/ Oligodendrocytes, 157/ function of, 155, 156t in myelin sheath, 156 Oligosaccharides, production of, 588, 588/ Oligospermia, 652 Olive oil and gastric function, 584 saturated fat content of, 34 Omega-3 fatty acids, 600 On-center fields, 275, 276/

Oncogenes, 71 Oncology, 468 Oncotic pressure, 413 Ondine's curse, 500 Oocytes, 657/ after fertilization, 666/, 667 primary, 656 secondary, 657, 657/ Oogenesis, 640, 659/ Oogonia, 635, 656 Ophthalmia, sympathetic, 470, 470t Opiates, synaptic effects of, 207t Opioid(s)

endogenous, as neurotransmitters, 180, 180t receptor proteins for, 180 Opsin, 269, 270/ Opsonization, 452, 456, 457 Optic chiasma, 274 Optic disc, 263 Optic nerve, 212t

Optic neuropathy, Leber's hereditary, 58 Optic radiation, 276

Optic tectum. See Colliculus(i), superior Oral cavity, 561, 561/ Oral contraceptives, 663-664 Oral rehydration therapy, 138 Orbitals, 24

Organ(s). See also speci/ic organs definition of, 10, 17 dual innervation of, 234-235, 234t target, 9 Organ of Corti, 258-261, 259/ Organelles, 55-59 definition of, 51 digestion of, 56, 57 Organic acids, 29, 31/ Organic anion transporters, 540 Organic molecules, 29-31 Orgasm, 643

Origin, of skeletal muscle, 326 Orphan receptors, 293 Orthostatic hypotension, 432 Oscilloscope, 160, 160/ Osmolality, 132, 132/ of blood, regulation of, 133-134, 134/, 416,

416/, 417 of kidneys, 538/ measurement of, 132 Osmoreceptors, 134, 416 Osmosis, 130-133 definition of, 127, 128 effects of, 130, 131/ model of, 130/ requirements for, 130 Osmotic pressure, 130-131, 131/ colloid, 413

ionization and, 132, 133/ Ossicles, middle-ear, 255

damage to, 257 Osteitis deformans, alkaline phosphatase concentrations and, 88t Osteitis fibrosa cystica, 627 Osteoblasts, 16, 623 Osteoclasts, 623, 623/ Osteocytes, 16, 17/ Osteomalacia, 627 Osteoporosis, 624-625, 625/ Otic ganglion, 224-225 Otitis media, 257

Otolithic membrane, 253

Otosclerosis, 257

Outer ear, 255, 256/

Ova. See Ovum

Oval window, 255

Ovarian cycle, 655-657, 662/

endocrine control of, 663/ Ovarian follicles, 315 development of, 636, 656, 657, 658/, 660/ mature, 657 primary, 656-657 secondary, 657 Ovary(ies), 654/, 655/, 656/ cyclic changes in, 660-661 endocrine functions of, 14, 287t exocrine functions of, 14 formation of, 635-637, 636/ sex steroid secretion by, 37 Overeating, 604, 605 Ovotestes, 639

Ovulatory phase, of menstrual cycle, 664t Ovum, 315 development of, 660/ mitochondria in, 58

Oxaloacetic acid, in Krebs cycle, 109, 110 Oxidase, pH optimum of, 90/ Oxidation, 96, 98/ agents of, 96, 98/ 3-Oxidation, 115, 116/ Oxidation-reduction reactions, 96, 98/ 104 Oxidative deamination, 117-118, 118/ Oxidative fibers fast, 345 slow, 344-345 Oxidative phosphorylation, 111, 111/, 112.

113,113/ Oxidative stress, 111, 603 Oxygen in aerobic cell respiration, 104 in blood, 379, 496-497, 504-505, 504/ measurement of, 494-496 significance of, 503, 503/ debt, 119, 344

diffusion through plasma membrane, 128 in electron transport, 112-113 free radicals of, 111 in gas exchange, 480 hemoglobin affinity for, altitude and, 515 maximal uptake of, 343-344, 346-347 in oxidation-reduction reactions, 96 partial pressure of, 493 altitude and, 494, 495/ calculation of, 494-496 significance of, 496-497 and ventilation, 503 reactive species of, 111, 603, 604/ structure of, 24/ toxicity, 498

utilization of, in respiration, 480 Oxygen electrode, 494-496, 496/ Oxygen therapy, hyperbaric, 498 Oxygen toxicity, 498 Oxygen transport, 504-510 2,3-diphosphoglyceric acid and, 508, 508/ pH and, 507-508, 507/ temperature and, 507-508, 508/ Oxyhemoglobin, 367, 504 saturation of, and partial oxygen pressure, 506, 506/ Oxyhemoglobin dissociation curve, 506-507, 506/ 2,3-diphosphoglyceric acid and, 508, 508/ pH and, 507-508, 507/, 508/ Oxytocin, 288/ function of, 205, 300-301, 674-676 and milk letdown, 678 production of, 205

Was this article helpful?

0 0
Supplements For Diabetics

Supplements For Diabetics

All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.

Get My Free Ebook


Post a comment